NASDAQ:BIOL BIOLASE (BIOL) Short Interest Ratio & Short Volume $1.74 +0.03 (+1.75%) (As of 09/21/2023 ET) Add Compare Share Share Today's Range$1.56▼$2.1050-Day Range$1.71▼$675.0052-Week Range$1.56▼$279.00Volume2.19 million shsAverage Volume132,403 shsMarket Capitalization$1.81 millionP/E RatioN/ADividend YieldN/APrice Target$513.50 Short InterestProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media BIOLASE Short Interest DataCurrent Short Volume161,600 sharesPrevious Short Volume154,100 sharesChange Vs. Previous Month+4.87%Dollar Volume Sold Short$706,192.00Short Interest Ratio / Days to Cover0.7Last Record DateAugust 31, 2023Outstanding Shares1,040,000 sharesFloat Size1,000,000 sharesShort Percent of Float16.16%Today's Trading Volume2,194,421 sharesAverage Trading Volume132,403 sharesToday's Volume Vs. Average1,657% Short Selling BIOLASE ? Sign up to receive the latest short interest report for BIOLASE and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIOL Short Interest Over TimeBIOL Days to Cover Over TimeBIOL Percentage of Float Shorted Over Time BIOLASE (NASDAQ:BIOL) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/2023161,600 shares $706,192.00 +4.9%16.2%0.7 $4.37 8/15/2023154,100 shares $947,715.00 -61.4%15.4%0.7 $6.15 7/31/2023399,400 shares $2.43 million -87.2%40.2%2.1 $6.09 7/15/20233,110,000 shares $270,259.00 -44.4%3.8%0.4 $0.09 6/30/20235,590,000 shares $395,213.00 +589.1%6.9%0.7 $0.07 6/15/2023811,200 shares $64,084.80 -61.2%1.1%0.2 $0.08 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 5/31/20232,090,000 shares $170,335.00 +145.4%8.0%0.6 $0.08 5/15/2023851,600 shares $183,008.84 +4.4%3.7%0.5 $0.21 4/30/2023815,700 shares $203,925.00 +219.5%4.1%0.8 $0.25 4/15/2023255,300 shares $61,833.66 +140.9%1.3%0.3 $0.24 3/31/2023106,000 shares $29,807.20 +127.0%0.5%0.2 $0.28 3/15/202346,700 shares $18,213.00 -59.2%0.2%0.1 $0.39 2/28/2023114,500 shares $58,395.00 -42.4%0.6%0.2 $0.51 2/15/2023198,900 shares $101,399.22 -29.1%1.0%0.3 $0.51 1/31/2023280,400 shares $152,313.28 -31.9%1.4%0.5 $0.54 1/15/2023411,800 shares $175,591.52 -36.7%12.8%0.9 $0.43 12/30/2022650,300 shares $422,695.00 -7.1%9.3%2.7 $0.65 12/15/2022700,100 shares $467,316.75 +108.5%10.0%5.1 $0.67 11/30/2022335,800 shares $324,382.80 +144.2%4.8%3 $0.97 11/15/2022137,500 shares $247,500.00 +8.4%2.0%1.8 $1.80 10/31/2022126,900 shares $248,724.00 -2.0%1.9%3.7 $1.96 10/15/2022129,500 shares $268,065.00 +5.0%1.9%3.9 $2.07 9/30/2022123,300 shares $299,619.00 +5.7%1.8%3.7 $2.43 9/15/2022116,700 shares $378,108.00 +6.4%1.7%3.2 $3.24 8/31/2022109,700 shares $424,539.00 -23.9%1.6%3.1 $3.87 8/15/2022144,200 shares $733,257.00 -22.6%2.1%3.9 $5.09 7/31/2022186,300 shares $825,309.00 -13.2%2.8%4.6 $4.43 7/15/2022214,500 shares $890,175.00 -13.2%3.2%3.7 $4.15 6/30/2022247,200 shares $1.13 million +3.5%3.3%4.2 $4.58 6/15/2022238,800 shares $1.03 million -14.7%4.0%4.2 $4.31 5/31/2022280,100 shares $1.35 million -0.4%4.6%4.4 $4.83 5/15/2022281,300 shares $1.12 million -45.3%4.7%4.3 $3.99 4/30/2022514,100 shares $2.36 million -89.5%8.5%8.5 $4.60 4/15/20224,910,000 shares $1.51 million +1.7%N/A4.3 $0.31 3/31/20224,830,000 shares $1.71 million +14.2%N/A3.8 $0.35 3/15/20224,230,000 shares $1.35 million -16.4%N/A2 $0.32 2/28/20225,060,000 shares $1.78 million +14.0%3.4%2.3 $0.35 2/15/20224,440,000 shares $1.77 million -18.2%3.0%1.6 $0.40 1/31/20225,430,000 shares $2.01 million -7.8%3.6%1.7 $0.37 1/15/20225,890,000 shares $2.37 million -11.4%3.9%1.8 $0.40 BIOL Short Interest - Frequently Asked Questions What is BIOLASE's current short interest? Short interest is the volume of BIOLASE shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 161,600 shares of BIOL short. 16.16% of BIOLASE's shares are currently sold short. Learn More on BIOLASE's current short interest. What is a good short interest ratio for BIOLASE? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOL shares currently have a short interest ratio of 1.0. Learn More on BIOLASE's short interest ratio. What is a good short interest percentage for BIOLASE? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.16% of BIOLASE's floating shares are currently sold short. Is BIOLASE's short interest increasing or decreasing? BIOLASE saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 161,600 shares, an increase of 4.9% from the previous total of 154,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BIOLASE's float size? BIOLASE currently has issued a total of 1,040,000 shares. Some of BIOLASE's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BIOLASE currently has a public float of 1,000,000 shares. How does BIOLASE's short interest compare to its competitors? 16.16% of BIOLASE's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BIOLASE: Bone Biologics Co. (0.28%), OpGen, Inc. (3.10%), Allarity Therapeutics, Inc. (0.91%), ReShape Lifesciences Inc. (1.12%), Akanda Corp. (3.39%), SQZ Biotechnologies (3.77%), Infinity Pharmaceuticals, Inc. (2.43%), Motus GI Holdings, Inc. (2.82%), Scopus BioPharma Inc. (0.84%), Avalo Therapeutics, Inc. (5.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short BIOLASE stock? Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BIOLASE? A short squeeze for BIOLASE occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOL, which in turn drives the price of the stock up even further. How often is BIOLASE's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOL, twice per month. The most recent reporting period available is August, 31 2023. More Short Interest Resources from MarketBeat Related Companies: BBLG Short Interest Data OPGN Short Interest Data ALLR Short Interest Data RSLS Short Interest Data AKAN Short Interest Data SQZ Short Interest Data INFI Short Interest Data MOTS Short Interest Data SCPS Short Interest Data AVTX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIOL) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.